Thermodynamically stable crystal modification of 2-methyl-N-(5-methyl-1, 3, 4-oxadiazol-2-yl)-3-(methylsulfonyl)-4-(trifluoromethyl)benzamide

US10336716B2 · kind B2 · utility

Assignee

• BAYER CROPSCIENCE AKTIENGESELLSCHAFT · DE

Inventors

• Arnim Köhn · Wiesbaden, DE
• Christopher Hugh Rosinger · Hofheim, DE
• Christian Waldraff · Bad Vilbel, DE
• Britta Olenik · Bottrop, DE
• Birgit Keil · Düsseldorf, DE
• Benedikt Mehl · Wuppertal, DE

Key dates

• Filing date: Nov 4, 2016
• Grant date: Jul 2, 2019
• Expiry date: Nov 4, 2036

Classification

• Technology area (CPC C): Chemistry; Metallurgy
• CPC primary: C07B2200/13
• WIPO field: Organic fine chemistry
• WIPO sector: Chemistry

Abstract

A thermodynamically stable crystal modification of 2-methyl-N-(5-methyl-1,3,4-oxadiazol-2-yl)-3-(methylsulfonyl)-4-(trifluoromethyl)benzamide is described. This thermodynamically stable crystal modification has particular advantages in the stability of suspension formulations.